Pradaxa patients may have a better chance of surviving emergency surgeries, due to a recent study using 5g of idarucizumab (humanized antibody fragments). In critical cases, such as patients with uncontrolled bleeding, intracranial hemorrhage, or severe trauma following an automobile accident, there is a marginally improved chance for the patient to survive invasive procedures. The specific study mentioned that the timing of the treatment is crucial, such as administering the anticoagulant within four hours. Normal results occurred 92% of the time, under controlled circumstances in the study from Boehringer Ingelheim. Results of the study were presented at the European Society of Cardiology Congress 2015.
Legal Commentary
Our Pradaxa attorneys at Nachawati Law Group are studying, examining and investigating current Pradaxa claims on behalf of patients and their families who may have been injured by the drug. If you or a loved one has experienced any side effects while taking Pradaxa, contact our Pradaxa lawyers to discuss the facts of your potential case.
About Nachawati Law Group
Nachawati Law Group represents parties in mass tort litigation, businesses and governmental entities in contingent litigation, and individuals in complex personal injury litigation. For more information, visit contact help@ntrial.com or call 214-890-0711.